Correlation studies on human body composition based on bioequivalence or pharmacokinetic trials

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500106352

Enrollment

Unknown

Registered

2025-07-22

Start date

2024-10-05

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Observation group:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Participants who have been successfully enrolled in the bioequivalence or pharmacokinetic trials at our hospital 2. Have signed the informed consent form, have a full understanding of the content, process, and risks of this study, and can communicate well with the researchers.

Exclusion criteria

Exclusion criteria: 1. Pregnant and breastfeeding women. 2. Individuals with metal implants in the body, such as pacemakers, artificial joints, etc. 3. Patients with severe heart disease or arrhythmia. 4. Patients with severe skin diseases or skin damage that may affect the measurement results. 5. Participants who may not be able to complete the study for other reasons or are deemed by the investigator to be unsuitable for participation in this study.

Design outcomes

Primary

Measure	Time frame
Body composition;	—

Secondary

Measure	Time frame
percent body fat;	—

Countries

China

Contacts

Public ContactLi Ting

The Second Affiliated Hospital and Yuying Children's Hospital Affiliated to Wenzhou Medical University

liting1021@aliyun.com+86 135 8787 6896

Outcome results